Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa.

Tytuł:
Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa.
Autorzy:
Muchiri E; The Aurum Institute, Johannesburg, South Africa.
Charalambous S; The Aurum Institute, Johannesburg, South Africa.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Ginindza S; The Aurum Institute, Johannesburg, South Africa.
Maraisane M; The Aurum Institute, Johannesburg, South Africa.
Maringa T; CDC South Africa, Pretoria, South Africa.
Vranken P; CDC South Africa, Pretoria, South Africa.
Loykissoonlal D; National Department of Health, Johannesburg, South Africa.
Muturi-Kioi V; International AIDS Vaccine Initiative (IAVI), Nairobi, Kenya.
Chetty-Makkan CM; The Aurum Institute, Johannesburg, South Africa.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Źródło:
PloS one [PLoS One] 2021 Aug 17; Vol. 16 (8), pp. e0253960. Date of Electronic Publication: 2021 Aug 17 (Print Publication: 2021).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Infections*/epidemiology
Infections*/etiology
Voluntary Programs*
Circumcision, Male/*adverse effects
Postoperative Hemorrhage/*epidemiology
Adolescent ; Adult ; Africa, Southern/epidemiology ; Follow-Up Studies ; HIV Infections/prevention & control ; HIV-1 ; Humans ; Male ; Middle Aged ; Retrospective Studies ; South Africa
References:
Popul Health Metr. 2016 Mar 01;14:4. (PMID: 26933388)
Bull World Health Organ. 2008 Sep;86(9):669-77. (PMID: 18797642)
BMC Public Health. 2012 Jan 22;12:67. (PMID: 22264256)
PLoS One. 2018 Mar 26;13(3):e0194271. (PMID: 29579082)
Lancet. 2007 Feb 24;369(9562):657-66. (PMID: 17321311)
PLoS Med. 2005 Nov;2(11):e298. (PMID: 16231970)
PLoS Med. 2011 Nov;8(11):e1001132. (PMID: 22140367)
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):465-70. (PMID: 23242159)
AIDS Res Treat. 2018 May 3;2018:8387436. (PMID: 29854445)
PLoS One. 2016 Oct 26;11(10):e0155734. (PMID: 27783681)
Lancet. 2007 Feb 24;369(9562):643-56. (PMID: 17321310)
Glob Public Health. 2019 Jan;14(1):91-111. (PMID: 29695201)
Arch Sex Behav. 2020 Apr;49(3):983-998. (PMID: 31997131)
PLoS One. 2017 Apr 17;12(4):e0175873. (PMID: 28414783)
AIDS Behav. 2020 Jan;24(1):344. (PMID: 31214865)
Bull World Health Organ. 2010 Dec 1;88(12):907-14. (PMID: 21124715)
BMC Health Serv Res. 2016 Feb 17;16:61. (PMID: 26888178)
Popul Health Metr. 2016 Apr 04;14:11. (PMID: 27051352)
PLoS One. 2016 Jul 13;11(7):e0157071. (PMID: 27409079)
AIDS Care. 2016 Aug;28(8):1007-12. (PMID: 26754167)
J Int AIDS Soc. 2017 Feb 20;19(1):21394. (PMID: 28362066)
PLoS Med. 2016 May 03;13(5):e1002012. (PMID: 27138961)
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S49-55. (PMID: 27331590)
PLoS One. 2014 May 06;9(5):e85051. (PMID: 24802746)
Cancer Control. 2004 Nov-Dec;11(6):388-96. (PMID: 15625526)
PLoS One. 2018 Jan 19;13(1):e0190795. (PMID: 29351311)
AIDS Care. 2007 Apr;19(4):471-7. (PMID: 17453585)
Cult Health Sex. 2013;15(9):1085-100. (PMID: 23815101)
MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):337-339. (PMID: 29565839)
Lancet. 2007 May 12;369(9573):1597; author reply 1598-9. (PMID: 17499590)
J Int AIDS Soc. 2018 Jan;21(1):. (PMID: 29359533)
PLoS One. 2016 Oct 26;11(10):e0160699. (PMID: 27783613)
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S166-S172. (PMID: 29617778)
AIDS Behav. 2007 May;11(3):341-55. (PMID: 17053855)
AIDS Care. 2011 Dec;23(12):1578-85. (PMID: 21732902)
J Int AIDS Soc. 2019 Jul;22(7):e25369. (PMID: 31368235)
Grant Information:
U01 GH000522 United States GH CGH CDC HHS; United States PEPFAR PEPFAR
Entry Date(s):
Date Created: 20210817 Date Completed: 20211123 Latest Revision: 20240404
Update Code:
20240404
PubMed Central ID:
PMC8370616
DOI:
10.1371/journal.pone.0253960
PMID:
34403409
Czasopismo naukowe
Background: Clinical trials showed strong evidence that voluntary medical male circumcision (VMMC) reduces the acquisition of HIV among heterosexual men by up to 60%. However, VMMC uptake in East and Southern Africa remains suboptimal, with safety concerns identified as a barrier to uptake. We investigated the occurrence and severity of adverse events (AEs) in a routine VMMC programme implemented in Gauteng and North West provinces of South Africa.
Methods: We describe the frequency and characteristics of AEs using routinely collected data from a VMMC programme implemented between 01 May 2013 and 31 December 2014. The surgical procedure was provided at fixed clinics and mobile units in three districts. Adult men undertaking the procedure were referred for follow-up appointments where AEs were monitored.
Results: A total of 7,963 adult men were offered the VMMC service with 7,864 (98.8%) met the age and consent requirements for inclusion in a research follow-up after the surgical procedure and were followed-up for potential AEs. In total, 37 (0.5%) patients reported AEs post-surgery with infection [11 (29.7%)] and excessive bleeding [11 (29.7%)] commonly reported AEs. In terms of severity, 14 (37.8%) were classified as mild, 13 (35.1%) as moderate, and 10 (27.0%) as severe. Further, 32 (86.5%) of the AEs were classified as definitely related to the surgical procedure, with 36 (97.5%) of all AEs resolving without sequelae.
Conclusion: The VMMC programme was able to reach adult men at high risk of HIV acquisition. Reported AEs in the programme were minimal, with the observed safety profile comparable to clinical trial settings, suggesting that VMMC can be safely administered in a programmatic setting.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies